The journal covers a wide range of topics pertinent to cancer pharmacology. These include the development of targeted therapies, the role of biomarkers in predicting treatment outcomes, and the impact of genetic variations on drug metabolism. Research on drug resistance, which is a significant challenge in cancer treatment, is also a focus area, offering insights into overcoming resistance mechanisms.
